ELEDON PHARMACEUTICALS INC (ELDN)

US28617K1016 - Common Stock

1.99  +0.42 (+26.75%)

After market: 2.13 +0.14 (+7.04%)

Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to ELDN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 15.91. This target is 699.6% above the current price.
ELDN was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ELDN.
In the previous month the buy percentage consensus was at a similar level.
ELDN was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

Price Target & Forecast

Price Low Median Mean High 1.997.0710.2015.9140.95 - 255.28% 412.56% 699.60% 1,957.79%

Related screens

Up and Down Grades
Date Firm Action Rating
2024-03-22 HC Wainwright & Co. Reiterate Buy -> Buy
2023-11-13 HC Wainwright & Co. Reiterate Buy -> Buy
2023-10-24 HC Wainwright & Co. Maintains Buy -> Buy
2023-09-27 Noble Capital Markets Initiate Outperform
2023-08-22 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-05-26 HC Wainwright & Co. Reiterate Buy -> Buy
2022-06-01 SVB Leerink Maintains Outperform
2021-11-24 HC Wainwright & Co. Maintains Buy
2021-04-27 SVB Leerink Maintains Outperform
2021-03-23 Cantor Fitzgerald Initiate Overweight
2021-02-08 SVB Leerink Initiate Outperform